Next Article in Journal
Neuroendocrine Blockade of the Reproductive Axis in Female Athletes
Next Article in Special Issue
Looking at Diabetes-Related Distress through a New Lens: The Socio-Ecological Health Model
Previous Article in Journal
Updates of Genomics and Proteomics of Parathyroid Carcinoma
 
 
Article
Peer-Review Record

Cost-Effectiveness of Screening to Identify Pre-Diabetes and Diabetes in the Oral Healthcare Setting

Endocrines 2022, 3(4), 753-764; https://doi.org/10.3390/endocrines3040062
by Lan Gao 1,*, Elise Tan 1, Rodrigo Mariño 2, Michelle King 2, Andre Priede 2, Geoff Adams 2, Maria Sicari 2 and Marj Moodie 1
Reviewer 1:
Reviewer 2:
Endocrines 2022, 3(4), 753-764; https://doi.org/10.3390/endocrines3040062
Submission received: 28 September 2022 / Revised: 27 October 2022 / Accepted: 1 November 2022 / Published: 1 December 2022
(This article belongs to the Special Issue Advances in Diabetes Care)

Round 1

Reviewer 1 Report

see attached file

Comments for author File: Comments.docx

Author Response

Thank you very much for your comments. Please find our response in the attached document.

Author Response File: Author Response.docx

Reviewer 2 Report

This research investigated the effect of oral health screening regarding costs on detecting dysglycemia persons. The issue seems to be important. There are several considerations about scientific methods as below. 

-          I recommend you write full name with an abbreviation at the start of a word in the entire manuscript to better understand.

-          Please explain more detail about the AUDSRISK study. I have no idea why authors performed screening diabetes in oral health setting, because you didn't use dental data (as you mentioned you did periodontal assessment) for screening diabetes.

-          In methods, you mentioned that you calculated medical and non-medical costs, but you didn’t present respectively. So, it is hard to understand the result.

-          The order of the tables is incorrectly marked.

-          Please clarify the fig 1, a decision tree model including probability, outcome, terminal node, chance node, and decision node to estimate the impact on cost-effectiveness.

-          Is this including oral medical expenditures in this cost analysis? It is necessary to clearly define not only the indication, frequency, and interval of medical treatment currently being evaluated, but also what input factors (people, resources) are needed to implement the medical treatment, and whether there are other accompanying medical treatment to be implemented together.

-          What criteria is the intervention reach of various levels (10%; 20%; 30% and 40%)?

Author Response

Thank you very much for your comments. Please find our response in the attached document.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

The revisions and responses address my comment well. No further comment from me.

Reviewer 2 Report

None.

Back to TopTop